Lantern Pharma Inc.
Clinical trials sponsored by Lantern Pharma Inc., explained in plain language.
-
New drug LP-284 enters human testing for tough cancers
Disease control Recruiting nowThis early-phase trial tests an experimental drug called LP-284 in about 110 adults whose lymphomas or solid tumors have come back or stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug shrinks tumors. Researchers will also monito…
Phase: PHASE1 • Sponsor: Lantern Pharma Inc. • Aim: Disease control
Last updated May 26, 2026 06:50 UTC
-
New hope for never-smokers with lung cancer: experimental combo targets resistant tumors
Disease control Recruiting nowThis study tests whether adding the experimental drug LP-300 to standard chemotherapy can help people who have never smoked and have advanced lung cancer that stopped responding to targeted therapy. About 90 participants will receive either the drug combo or chemo alone. The goal…
Phase: PHASE2 • Sponsor: Lantern Pharma Inc. • Aim: Disease control
Last updated May 26, 2026 06:49 UTC